Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Behzad Baradaran

Showing results (571-580 of 707) with videos related to

Pageof 71
Sort By:
Human Immunology|March 20, 2025
Pyrimethamine treatment in breast cancer lysate-loaded dendritic cells promotes autologous T cells' anti-tumor responses in vitroSepideh Sohrabi, Javad Masoumi, Bahar Naseri, et al.
Medical Oncology (Northwood, London, England)|July 2, 2024
CTLA-4 silencing could promote anti-tumor effects in hepatocellularAmirhossein Mardi, Mahsan Alizadeh, Amir Shahabaddin Abdolalizadeh, et al.
Bioimpacts : BI|June 28, 2024
Cooperatively inhibition effect of miR-143-5p and miR-145-5p in tumorigenesis of glioblastoma cells through modulating AKT signaling pathwaySheyda Jodeiry Zaer, Mahmoudreza Aghamaali, Mohammad Amini, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 15, 2024
MicroRNA-143 overexpression enhances the chemosensitivity of A172 glioblastoma cells to carmustineSheyda Jodeiry Zaer, Mahmoudreza Aghamaali, Souzan Najafi, et al.
Molecular Biology Reports|April 5, 2020
CD133 suppression increases the sensitivity of prostate cancer cells to paclitaxelMarjan Aghajani, Ahad Mokhtarzadeh, Leili Aghebati-Maleki, et al.
Frontiers in Immunology|March 8, 2021
STAT3 Silencing and TLR7/8 Pathway Activation Repolarize and Suppress Myeloid-Derived Suppressor Cells From Breast Cancer PatientsElham Safarzadeh, Ali Mohammadi, Behzad Mansoori, et al.
Life Sciences|March 31, 2021
MiR-142-3p targets HMGA2 and suppresses breast cancer malignancyBehzad Mansoori, Pascal H G Duijf, Ali Mohammadi, et al.
Frontiers in Medicine|November 17, 2022
A scoping review on the significance of programmed death-ligand 1-inhibiting microRNAs in non-small cell lung treatment: A single-cell RNA sequencing-based studyMahdi Abdoli Shadbad, Farid Ghorbaninezhad, Hamidreza Hassanian, et al.
Cancer Treatment and Research Communications|October 4, 2025
Photodynamic therapy with zinc phthalocyanine enhances cisplatin sensitivity of human muscle-invasive bladder cancer cells by downregulation of PI3K/AKT/mTOR signaling pathwayFateme Mohammadnejad, Neda Rajabi, Mohammad Amin Doustvandi, et al.
Journal of Clinical Laboratory Analysis|September 16, 2021
Identification of a compound heterozygous missense mutation in LAMA2 gene from a patient with merosin-deficient congenital muscular dystrophy type 1AAfshin Khorrami, Pouya Goleij, Vahidreza Karamad, et al.
Pageof 71

Showing results (571-580 of 707) with videos related to

Sort By:
Pageof 71
Human Immunology|March 20, 2025
Pyrimethamine treatment in breast cancer lysate-loaded dendritic cells promotes autologous T cells' anti-tumor responses in vitroSepideh Sohrabi, Javad Masoumi, Bahar Naseri, et al.
Medical Oncology (Northwood, London, England)|July 2, 2024
CTLA-4 silencing could promote anti-tumor effects in hepatocellularAmirhossein Mardi, Mahsan Alizadeh, Amir Shahabaddin Abdolalizadeh, et al.
Bioimpacts : BI|June 28, 2024
Cooperatively inhibition effect of miR-143-5p and miR-145-5p in tumorigenesis of glioblastoma cells through modulating AKT signaling pathwaySheyda Jodeiry Zaer, Mahmoudreza Aghamaali, Mohammad Amini, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 15, 2024
MicroRNA-143 overexpression enhances the chemosensitivity of A172 glioblastoma cells to carmustineSheyda Jodeiry Zaer, Mahmoudreza Aghamaali, Souzan Najafi, et al.
Molecular Biology Reports|April 5, 2020
CD133 suppression increases the sensitivity of prostate cancer cells to paclitaxelMarjan Aghajani, Ahad Mokhtarzadeh, Leili Aghebati-Maleki, et al.
Frontiers in Immunology|March 8, 2021
STAT3 Silencing and TLR7/8 Pathway Activation Repolarize and Suppress Myeloid-Derived Suppressor Cells From Breast Cancer PatientsElham Safarzadeh, Ali Mohammadi, Behzad Mansoori, et al.
Life Sciences|March 31, 2021
MiR-142-3p targets HMGA2 and suppresses breast cancer malignancyBehzad Mansoori, Pascal H G Duijf, Ali Mohammadi, et al.
Frontiers in Medicine|November 17, 2022
A scoping review on the significance of programmed death-ligand 1-inhibiting microRNAs in non-small cell lung treatment: A single-cell RNA sequencing-based studyMahdi Abdoli Shadbad, Farid Ghorbaninezhad, Hamidreza Hassanian, et al.
Cancer Treatment and Research Communications|October 4, 2025
Photodynamic therapy with zinc phthalocyanine enhances cisplatin sensitivity of human muscle-invasive bladder cancer cells by downregulation of PI3K/AKT/mTOR signaling pathwayFateme Mohammadnejad, Neda Rajabi, Mohammad Amin Doustvandi, et al.
Journal of Clinical Laboratory Analysis|September 16, 2021
Identification of a compound heterozygous missense mutation in LAMA2 gene from a patient with merosin-deficient congenital muscular dystrophy type 1AAfshin Khorrami, Pouya Goleij, Vahidreza Karamad, et al.
Pageof 71